Aimei Health Technology Co., Ltd. filings document the regulatory record of a Cayman Islands blank-check company with ordinary shares, units and rights registered for Nasdaq trading. The filings describe SPAC mechanics such as trust-account funding, redemption-related timelines, deadline extensions, shareholder voting procedures and amendments to governing documents.
Recent 8-K, proxy and late-filing records also disclose direct financial obligations, unsecured promissory notes used to fund extension payments, capital-structure terms, material agreements, Nasdaq listing-compliance notices, delayed annual-report reporting and governance matters associated with the company's initial business-combination process.
Aimei Health Technology (AFJK) reported shareholder approvals to proceed with its proposed business combination with United Hydrogen and related mergers. Shareholders also approved the issuance of approximately 157,568,133 newly issued ordinary shares in connection with the transaction, as described in the proxy materials.
The Business Combination Proposal and the Merger Proposal each passed with 70.80% of votes cast in favor (3,832,573 for; 1,580,804 against). The Share Issuance Proposal passed with 67.23% in favor (3,639,303 for; 1,774,074 against). An Adjournment Proposal also passed on the same vote totals as the Share Issuance Proposal. As of the record date on September 26, 2025, ordinary shares outstanding were 6,121,733; this is a baseline figure, not the amount being issued.
Following the approvals, 3,950,411 Public Shares were tendered for redemption. The company also outlined an extension meeting to allow more time to close if the business combination is not completed before December 6, 2025.
Aimei Health Technology (AFJK) called an Extraordinary General Meeting on November 26, 2025 to vote on four items that shape its SPAC timeline and governance. The key proposal amends Article 35.2 to extend the deadline to complete a business combination from 24 months to as late as 36 months from the IPO, moving the termination date to December 6, 2026. A related proposal would amend the Trust Agreement to reduce each monthly extension payment by the Sponsor to the lesser of $80,000 for all outstanding Public Shares or $0.033 per outstanding Public Share.
If the article amendment is approved, public shareholders may elect to redeem at a per‑share amount equal to the Trust Account balance divided by Public Shares; this was approximately $11.33 per Public Share as of September 26, 2025. The redemption deadline is 5:00 p.m. ET on November 24, 2025, with delivery via DWAC or certificates. Shareholders will also vote on appointing MaloneBailey, LLP as auditor for 2025 and authorizing potential adjournment to solicit additional votes.
Aimei Health Technology (AFJK) extended its merger deadline by one month after depositing $150,000 into its trust account, moving the termination date from November 6, 2025 to December 6, 2025. This is the twelfth and final extension permitted under its articles.
To fund the deposit, AFJK issued an unsecured $150,000 promissory note on November 4, 2025 to its sponsor and United Hydrogen Group Inc., split $75,000 each. The note bears no interest and becomes due upon consummation of the proposed business combination with United Hydrogen. The payees may convert the note into private units at $10.00 per unit—each unit comprising one ordinary share and one right to receive one-fifth of one ordinary share—immediately prior to closing, with at least two business days’ written notice.
Aimei Health Technology (AFJK) filed a preliminary proxy calling an extraordinary general meeting on November 26, 2025 to vote on four proposals. The key item seeks to amend the Articles to extend the SPAC deadline from 24 months to 36 months, pushing the termination date to December 6, 2026. A related trust amendment would reduce each monthly extension payment to the lesser of $80,000 for all outstanding Public Shares or $0.033 per Public Share, payable by the Sponsor.
If the Article Amendment is approved, Public Shareholders may elect to redeem their shares for their pro rata portion of the trust. As context, the per‑share trust amount was approximately $11.33 as of September 26, 2025, and the redemption deadline is 5:00 p.m. ET on November 24, 2025. Additional proposals ask shareholders to appoint MaloneBailey, LLP as auditor for 2025 and to allow meeting adjournment if needed. The Article Amendment requires at least two‑thirds of votes cast; the other proposals require a simple majority.
Aimei Health and United Hydrogen Global Inc. have agreed to a business combination that would merge United Hydrogen into a newly renamed Pubco and convert the outstanding securities of both targets into Pubco ordinary shares. Shareholders will vote at an Extraordinary General Meeting on November 6, 2025 on the Business Combination Proposal, the Merger Proposal, the Share Issuance Proposal and an Adjournment Proposal.
The transaction is structured on a pre-money equity value of $1,500,000,000 with consideration paid in Pubco common stock at $10 per share, implying the issuance of up to approximately 157,568,133 new ordinary shares to satisfy Nasdaq listing requirements. Major United Hydrogen shareholders will face a 6% lock-up period following closing (six months). The surviving Pubco will adopt a dual-class capital structure with Class A shares carrying one vote and Class B shares carrying ten votes, and an initial five-member board (three independent directors required).
Aimei Health Technology Co., Ltd extended the deadline to complete its initial business combination by one month, moving the termination date from October 6, 2025 to November 6, 2025. To fund this extension, an aggregate $150,000 was deposited into the company’s trust account for public shareholders.
The company issued a $150,000 unsecured promissory note dated October 8, 2025 to its sponsor, Aimei Health Ltd, and United Hydrogen Group Inc., with each contributing $75,000. The note bears no interest and becomes payable when Aimei completes its business combination with United Hydrogen. The payees may choose to convert the note into private units at $10.00 per unit, with each unit consisting of one ordinary share and a right to receive one-fifth of one ordinary share, immediately prior to closing the business combination.